Clinical trial
Growth Hormone and Chromosome 18q- and Abnormal Growth
NCT00134420 · The University of Texas Health Science Center at San Antonio, Other · Completed
Key facts
| NCT number | NCT00134420 |
|---|---|
| Title | Growth Hormone and Chromosome 18q- and Abnormal Growth |
| Official title | Growth Hormone Trial for Children With 18q- and Abnormal Growth |
| Lead sponsor | The University of Texas Health Science Center at San Antonio, Other |
| Collaborators | South Texas Veterans Health Care System U.S. Fed Genentech, Inc. Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Loss of Chromosome 18q, Growth Hormone Deficiency |
| Intervention type | Drug, Procedure |
| Interventions | Nutropin AQ, Arginine and Clonidine Stimulation Testing, Growth Factors Laboratory Testing, Neuropsychological Testing |
| Enrollment | 20 |
| Start date | Feb 1, 2001 |
| Primary completion | Jun 1, 2005 |
| Completion | Jun 1, 2005 |
| First posted | Aug 24, 2005 |
| Last update posted | Aug 8, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: